<DOC>
	<DOCNO>NCT02546947</DOCNO>
	<brief_summary>Mortality Acute Respiratory Distress Syndrome ( ARDS ) high ( 40 60 % ) . Protective mechanical ventilation cornerstone ARDS therapeutic strategy . Recently , prospective multicenter study demonstrate short-term infusion neuromuscular block agent ( NMBA ) reduce hospital mortality . However , mechanism NMBAs could improve survival remain speculative dose NMBA need observe beneficial effect still debate . In hypoxemic ventilated patient , continuous cisatracurium infusion objective response orbicularis oculus train-of-four ( TOF ) stimulation objective two response similar effect respiratory parameter . In study , Papazian colleague use cisatracurium initial standard dose 15 mg follow continuous infusion 37.5mg/h , base previous result study patient monitor paralysis . Atracurium stereoisomer cisatracurium non-depolarizing neuromuscular blocking drug , use anaesthesia intensive care unit . The aim study compare ARDS patient dose adjustment continuous-atracurium intravenous infusion end point one two response orbicularis oculi TOF stimulation , dose adjustment achieve clinical goal protective ventilation without monitor TOF stimulation .</brief_summary>
	<brief_title>Monitoring Intensive Care Unit Neuromuscular Blocking Agents Used Acute Respiratory Distress Syndrome After Cardiothoracic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>ARDS PaO2 / FiO2 &lt; 200 PEEP &gt; 5 since less 48 hr Informed consent NMBA allergy Continuous administration NMBA ARDS prior inclusion Age &lt; 18 yr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Respiratory Distress Syndrome , Adult</keyword>
	<keyword>Neuromuscular Blocking Agents</keyword>
	<keyword>Atracurium</keyword>
	<keyword>Mechanical ventilation</keyword>
	<keyword>ARDS</keyword>
	<keyword>partial pressure oxygen ( PaO2 ) /inspired oxygen ( FiO2 ) &lt; 200</keyword>
	<keyword>Positive End Expiratory Pressure ( PEEP ) &gt; 5 since less 48 hr</keyword>
</DOC>